Comparative-Effectiveness Research in Molecular Imaging

Tuesday, June 7 | 2:30 PM - 4:00 PM
Room 006CD

Objectives
Upon completion of this activity, the participant will be able to:
1. Assess and interpret comparative-effectiveness research (CER) studies in terms of type of study design, research perspective, comparison groups, sub-population studied, primary findings, limitations and implications.
2. Develop CER study questions in molecular imaging modalities and develop hypotheses for and approaches to CER.
3. Discuss completely the broad implications of CER in molecular imaging and in medicine.

Speakers are:
Michael M. Graham, PhD, MD, University of Iowa Carver College of Medicine in Iowa City, Iowa;
Brian W. Bresnahan, PhD, Harborview Medical Center in Seattle; and
Daniel H. Silverman, MD, PhD, University of California, Los Angeles.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.